BBlogFlow
← Back to videos

A 3-Year-Old's Metastatic Cancer Disappeared After Two Doses of Experimental Therapy

ScienceAlert · Published on September 19, 2026

Play videoWatch on YouTube ↗

Loved this video? Share it!

Send it to someone who'll love it, or post it on your networks.

Facebook Twitter Email

Description

A powerful advance in cancer-fighting medicine has achieved an extraordinary new milestone. Chimeric Antigen Receptor (CAR) T cell therapy is an immunotherapy technique that involves taking a patient's immune cells and genetically engineering them to become potent cancer-hunting predators. The treatment has shown huge promise in helping patients treat cancer, although its effectiveness has mostly been limited to treating blood cancers, not solid tumors. But an inspirational real-life success story involving a three-year-old patient shows scientists are making big progress with CAR T cell therapy against solid tumors too – and with potentially life-saving results. In a report published in The New England Journal of Medicine, researchers document a case of complete regression of hepatoblastoma, a form of malignant liver cancer, in a 3-year-old boy, after CAR T cell treatment. Read more: https://www.sciencealert.com/a-3-year-olds-metastatic-cancer-disappeared-after-two-doses-of-experimental-therapy

View on YouTube

Facebook Twitter

See also